Cabaletta Bio (CABA) announced new and updated clinical data on CABA-201 demonstrating the potential to achieve drug-free, compelling clinical ...
The presentation entitled, " Safety and Efficacy Data from a Phase I Trial of Umbilical Lining Stem Cells (ULSCs) in Adult ...
They say lightning rarely strikes twice but Kezar Life Sciences has suffered its second clinical blow in as many months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback